Steven Cohen's AGIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 200,000 shares of Agios Pharmaceuticals, Inc. (AGIO) worth $5.44 M, representing 0.01% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in AGIO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 314,590 shares. Largest reduction occurred in Q4 2020, reducing 298,252 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Agios Pharmaceuticals (AGIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Agios Pharmaceuticals (AGIO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +193,493 | Add 2973.61% | 200,000 | $27.22 |
| Q3 2025 | +6,507 | New Buy | 6,507 | $40.14 |
| Q2 2021 | -101,100 | Sold Out | 0 | $0.00 |
| Q1 2021 | -78,500 | Reduce 43.71% | 101,100 | $51.64 |
| Q4 2020 | -298,252 | Reduce 62.42% | 179,600 | $43.33 |
| Q3 2020 | +144,593 | Add 43.39% | 477,852 | $35.00 |
| Q2 2020 | +202,645 | Add 155.15% | 333,259 | $53.48 |
| Q1 2020 | +130,614 | New Buy | 130,614 | $35.48 |
| Q3 2019 | -6,753 | Sold Out | 0 | $0.00 |
| Q2 2019 | -105,705 | Reduce 94.00% | 6,753 | $49.90 |
| Q1 2019 | -42,542 | Reduce 27.45% | 112,458 | $67.44 |
| Q4 2018 | -20,700 | Reduce 11.78% | 155,000 | $46.11 |
| Q3 2018 | +20,500 | Add 13.21% | 175,700 | $77.12 |
| Q2 2018 | -250,890 | Reduce 61.78% | 155,200 | $84.23 |
| Q1 2018 | +314,590 | Add 343.81% | 406,090 | $81.78 |
| Q4 2017 | -38,140 | Reduce 29.42% | 91,500 | $57.17 |
| Q3 2017 | -73,360 | Reduce 36.14% | 129,640 | $66.75 |
| Q2 2017 | +140,500 | Add 224.80% | 203,000 | $51.45 |
| Q1 2017 | -37,500 | Reduce 37.50% | 62,500 | $58.40 |
| Q4 2016 | +100,000 | New Buy | 100,000 | $41.73 |
| Q3 2014 | -46,100 | Sold Out | 0 | $0.00 |
| Q2 2014 | +46,100 | Add 0.00% | 46,100 | $45.81 |
Steven Cohen's Agios Pharmaceuticals Investment FAQs
Steven Cohen first purchased Agios Pharmaceuticals, Inc. (AGIO) in Q2 2014, acquiring 46,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Agios Pharmaceuticals, Inc. (AGIO) for 22 quarters since Q2 2014.
Steven Cohen's largest addition to Agios Pharmaceuticals, Inc. (AGIO) was in Q1 2018, adding 406,090 shares worth $33.21 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 200,000 shares of Agios Pharmaceuticals, Inc. (AGIO), valued at approximately $5.44 M.
As of the Q4 2025 filing, Agios Pharmaceuticals, Inc. (AGIO) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Agios Pharmaceuticals, Inc. (AGIO) was 477,852 shares, as reported at the end of Q3 2020.